Badawy SM - Search Results

1

Real-world evidence: Long-term safety of deferiprone in a large cohort of patients with sickle cell disease enrolled in a registry for up to 10 years.

Kwiatkowski JL, Thompson AA, Tricta F, Temin NT, Rozova A, Fradette C, Badawy SM. Kwiatkowski JL, et al. Among authors: badawy sm. Am J Hematol. 2024 Jun;99(6):1031-1039. doi: 10.1002/ajh.27276. Epub 2024 Mar 1. Am J Hematol. 2024. PMID: 38429922

2

Technology Access and Smartphone App Preferences for Medication Adherence in Adolescents and Young Adults With Sickle Cell Disease.

Badawy SM, Thompson AA, Liem RI. Badawy SM, et al. Pediatr Blood Cancer. 2016 May;63(5):848-52. doi: 10.1002/pbc.25905. Epub 2016 Feb 4. Pediatr Blood Cancer. 2016. PMID: 26844685

3

In-flight emergencies: Medical kits are not good enough for kids.

Badawy SM, Thompson AA, Sand M. Badawy SM, et al. J Paediatr Child Health. 2016 Apr;52(4):363-5. doi: 10.1111/jpc.13118. J Paediatr Child Health. 2016. PMID: 27145496 No abstract available.

4

Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.

Badawy SM, Liem RI, Rigsby CK, Labotka RJ, DeFreitas RA, Thompson AA. Badawy SM, et al. Br J Haematol. 2016 Nov;175(4):705-713. doi: 10.1111/bjh.14277. Epub 2016 Aug 10. Br J Haematol. 2016. PMID: 27507431 Free article.

5

Badawy SM, Thompson AA, Lai JS, Penedo FJ, Rychlik K, Liem RI. Badawy SM, et al. Pediatr Blood Cancer. 2017 Jun;64(6). doi: 10.1002/pbc.26369. Epub 2016 Nov 28. Pediatr Blood Cancer. 2017. PMID: 27896936 Clinical Trial.

6

Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease.

Badawy SM, Thompson AA, Penedo FJ, Lai JS, Rychlik K, Liem RI. Badawy SM, et al. Eur J Haematol. 2017 Jun;98(6):608-614. doi: 10.1111/ejh.12878. Epub 2017 Apr 17. Eur J Haematol. 2017. PMID: 28306171

7

Adherence to hydroxyurea, health-related quality of life domains, and patients' perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults.

Badawy SM, Thompson AA, Lai JS, Penedo FJ, Rychlik K, Liem RI. Badawy SM, et al. Health Qual Life Outcomes. 2017 Jul 5;15(1):136. doi: 10.1186/s12955-017-0713-x. Health Qual Life Outcomes. 2017. PMID: 28679417 Free PMC article.

8

Medication Adherence and Technology-Based Interventions for Adolescents With Chronic Health Conditions: A Few Key Considerations.

Badawy SM, Thompson AA, Kuhns LM. Badawy SM, et al. JMIR Mhealth Uhealth. 2017 Dec 22;5(12):e202. doi: 10.2196/mhealth.8310. JMIR Mhealth Uhealth. 2017. PMID: 29273573 Free PMC article.

9

Beliefs about hydroxyurea in youth with sickle cell disease.

Badawy SM, Thompson AA, Liem RI. Badawy SM, et al. Hematol Oncol Stem Cell Ther. 2018 Sep;11(3):142-148. doi: 10.1016/j.hemonc.2018.01.001. Epub 2018 Feb 2. Hematol Oncol Stem Cell Ther. 2018. PMID: 29397333 Free article. Clinical Trial.

10

Computer and mobile technology interventions to promote medication adherence and disease management in people with thalassemia.

Badawy SM, Morrone K, Thompson A, Palermo TM. Badawy SM, et al. Cochrane Database Syst Rev. 2017 Dec;2017(12):CD012900. doi: 10.1002/14651858.CD012900. Epub 2017 Dec 14. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Jun 28;6:CD012900. doi: 10.1002/14651858.CD012900.pub2 PMID: 29861660 Free PMC article. Updated.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters